[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-339591-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-339591-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","the-multifaceted-functionality-of-plasmacytoid-dendritic-cells-in-gastrointestinal-cancers-a-potential-therapeutic-target","The Multifaceted Functionality of Plasmacytoid Dendritic Cells in Gastrointestinal Cancers: A Potential Therapeutic Target?","","Gastrointestinal (GI) tumors create a substantial global health burden, driving the search for improved therapeutic strategies. Plasmacytoid dendritic cells (pDCs) are central to tumor immunity, yet they can exert both anti-tumor and pro-tumor influences. This review synthesizes evidence on pDC functions across multiple GI cancer types and evaluates their potential as therapeutic targets. Findings indicate that pDC infiltration can correlate with either worse or better outcomes depending on the cancer context. Further work is required to refine clinical translation and explore combination regimens.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/the-multifaceted-functionality-of-plasmacytoid-dendritic-cells-in-gastrointestinal-cancers-a-potential-therapeutic-target/339591/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/the-multifaceted-functionality-of-plasmacytoid-dendritic-cells-in-gastrointestinal-cancers-a-potential-therapeutic-target/339591.png","ImageObject",300,407,{"name":42,"@type":43},"Maeve","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-10-29","2026-09-21",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",8,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What role do plasmacytoid dendritic cells (pDCs) play in gastrointestinal tumors?","Question",{"text":63,"@type":64},"pDCs are important regulators of tumor immunity and can have both anti-tumor and pro-tumor effects, influencing tumor progression and immune control.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How does pDC infiltration relate to patient outcomes in different GI cancers?",{"text":68,"@type":64},"Higher pDC infiltration is associated with worse outcomes in gastric cancer, hepatocellular carcinoma, and intrahepatic cholangiocarcinoma, while it is linked to improved outcomes in esophageal, pancreatic, and colorectal cancers.",{"name":70,"@type":61,"acceptedAnswer":71},"Why might pDCs be promising as therapeutic targets?",{"text":72,"@type":64},"Because pDCs show complex but actionable influence on tumor immunity, initial animal studies suggest they could be successfully targeted in gastric cancer and hepatocellular carcinoma.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},339591,1791526789,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,111,114,119,122,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},7,"Healthcare",40,"healthcare",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":112,"slug":113},30,"research-report",{"id":115,"doc_module":4,"doc_module_name":25,"category_name":116,"show_sort_weight":117,"slug":118},9,"Religion & Spirituality",20,"religion-spirituality",{"id":117,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":117,"slug":121},"World Cup","world-cup",{"id":123,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":123,"slug":125},10,"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":55,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":139,"language":140,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":12,"update_tm":144,"read_time":109,"preview_page_count":33,"preview_urls":145},5909877438554,"https://ap-avatar.wpscdn.com/avatar/5600025385ad2bf12a7?_k=1778553567797529272","cancers   \nReview  \nThe Multifaceted Functionality of Plasmacytoid Dendritic Cells in Gastrointestinal Cancers: A Potential Therapeutic Target?  \nFrederik J. Hansen , Paul David * and Georg F. Weber *  \nCitation: Hansen, F.J.; David, P.; Weber, G.F. The Multifaceted Functionality of Plasmacytoid Dendritic Cells in Gastrointestinal Cancers: A Potential Therapeutic Target? Cancers 2024, 16, 2216 . [https://doi.org/10.3390/](https://doi.org/10.3390/)[ ](https://doi.org/10.3390/)cancers16122216  \nAcademic Editors: Sandra J. van Vliet and María Jesús Fernández Aceñero  \nReceived: 8 May 2024  \nRevised: 6 June 2024  \nAccepted: 12 June 2024  \nPublished: 13 June 2024  \nCopyright: © 2024 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license ([https://](https://)[ ](https://)[creativecommons.org/licenses/by/](creativecommons.org/licenses/by/)[ ](creativecommons.org/licenses/by/)[4.0/](4.0/)) .  \nDepartment of General and Visceral Surgery, Medical Faculty of Friedrich-Alexander-University Erlangen, University Hospital Erlangen, 91054 Erlangen, Germany; frederik.hansen@fau.de  \n* Correspondence: paul.david@uk-erlangen.de (P.D.); [georg.weber@uk-erlangen.de](georg.weber@uk-erlangen.de) (G.F.W.)  \nSimple Summary: Gastrointestinal (GI) tumors present a significant global health challenge, prompting the need for new therapeutic strategies. Plasmacytoid dendritic cells (pDCs) are crucial in tumor immunity, with both anti-tumor and pro-tumor effects. This review examines pDC roles in various GI tumors and their potential as therapeutic targets. In gastric cancer, hepatocellular carcinoma, and intrahepatic cholangiocarcinoma, higher pDC infiltration correlates with worse outcomes, whereas in esophageal, pancreatic, and colorectal cancers, it improves outcomes. Overall, pDCs have a complex role in GI tumors, affecting both tumor immunity and progression. Further research is needed torefine their clinical use and explore combination therapies.  \nAbstract: Gastrointestinal (GI) tumors pose a significant global health burden, necessitating the exploration of novel therapeutic approaches. Plasmacytoid dendritic cells (pDCs) play a crucial role in tumor immunity, exhibiting both anti-tumor and pro-tumor effects. This review aims to summarize the role of pDCs in different types of GI tumors and assess their potential as therapeutic targets. In gastric cancer, hepatocellular carcinoma, and intrahepatic cholangiocarcinoma, increased infiltration of pDCs was associated with a worse outcome, whereas in esophageal cancer, pancreatic cancer, and colorectal cancer, pDC infiltration improved the outcome. Initial animal studies of gastric cancer and hepatocellular carcinoma showed that pDCs could be a successful therapeutic target. In conclusion, pDCs play a multifaceted role in GI tumors, influencing both anti-tumor immunity and tumor progression. Further research is needed to optimize their clinical application and explore combinatorial approaches.  \nKeywords: plasmacytoid dendritic cells; pDCs; esophageal cancer; gastric cancer; hepatocellular carcinoma; cholangiocarcinoma; pancreatic cancer; colorectal cancer  \n1. Introduction  \nGastrointestinal (GI) tumors encompass a diverse group of malignancies arising from various organs within the digestive system, including the esophagus, stomach, liver, pancreas, and colorectum. These tumors represent a significant global health burden, contributing to high morbidity and mortality rates worldwide. They comprise 26% of total cancer cases and contribute to 35% of all cancer-related deaths [1] . The etiology of GI tumors is multifactorial, involving complex interactions between genetic predisposition, the immune system, environmental factors, and lifestyle choices [2] . While advancements in screening, diagnosis, and treatment have improved outcomes for some GI cancers, challenges persist in","cbCaiuAd5VT7fQOQ","https://ap.wps.com/l/cbCaiuAd5VT7fQOQ","pdf",944214,16,"English","# Simple Summary\n# Abstract\n# Keywords\n# 1. Introduction\n## Immunotherapy and tumor microenvironment\n# 2. Plasmacytoid dendritic cells and tumor immunity\n## Anti-tumor vs pro-tumor roles\n# 3. pDCs in specific gastrointestinal cancers\n## Gastric cancer, HCC, intrahepatic cholangiocarcinoma\n## Esophageal, pancreatic, and colorectal cancers\n# 4. Therapeutic implications and future directions","[{\"question\":\"What role do plasmacytoid dendritic cells (pDCs) play in gastrointestinal tumors?\",\"answer\":\"pDCs are important regulators of tumor immunity and can have both anti-tumor and pro-tumor effects, influencing tumor progression and immune control.\"},{\"question\":\"How does pDC infiltration relate to patient outcomes in different GI cancers?\",\"answer\":\"Higher pDC infiltration is associated with worse outcomes in gastric cancer, hepatocellular carcinoma, and intrahepatic cholangiocarcinoma, while it is linked to improved outcomes in esophageal, pancreatic, and colorectal cancers.\"},{\"question\":\"Why might pDCs be promising as therapeutic targets?\",\"answer\":\"Because pDCs show complex but actionable influence on tumor immunity, initial animal studies suggest they could be successfully targeted in gastric cancer and hepatocellular carcinoma.\"}]","The Multifaceted Functionality of Plasmacytoid Dendritic Cells in Gastrointestinal Cancers: A Potential Therapeutic Target? | PDF",1790031149,[146,150,154,158],{"page_no":22,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/290987ef09abd0d006b08ee4f7210feb.webp",983,1390,{"page_no":26,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/71f7d9ddf73973cce9c7f4fb44a03c26.webp",982,1388,{"page_no":30,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/0b03e1280809649e3122709c4f222e87.webp",981,1387,{"page_no":33,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/c0d11d5a8f07e03d9f5d04a895e7f127.webp",980,1385]